Dendritic Cell Tumor Fusion Vaccine

BIOLOGICAL2 trials

Sponsors

Beth Israel Deaconess Medical Center

Conditions

Multiple MyelomaRenal Cancer

Phase 1

The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma

CompletedNCT00459069

Beth Israel Deaconess Medical CenterMultiple Myeloma

Start: 2004-07-31End: 2009-11-30Updated: 2010-01-12

Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF

CompletedNCT00458536

Beth Israel Deaconess Medical CenterRenal Cancer

Start: 2004-10-01End: 2023-07-01Updated: 2026-02-09